A clinical analysis of juvenile dermatomyositis; focus on clinical manifestations at diagnosis.
10.3345/kjp.2007.50.11.1116
- Author:
So Young LEE
1
;
Ji Seok BANG
;
Hee Seok KIM
;
Joong Gon KIM
Author Information
1. Department of Pediatrics, College of Medicine, Seoul National University, Seoul, Korea. jgkim@snu.ac.kr
- Publication Type:Original Article
- Keywords:
Juvenile dermatomyositis;
Proximal muscle weakness;
Rash;
Calcinosis
- MeSH:
Antibodies, Antinuclear;
Biopsy;
Buttocks;
Calcinosis;
Child;
Dermatomyositis*;
Diagnosis*;
Electromyography;
Exanthema;
Female;
Fructose-Bisphosphate Aldolase;
Humans;
Magnetic Resonance Imaging;
Male;
Medical Records;
Muscle Weakness;
Myositis;
Retrospective Studies;
Seoul;
Sex Ratio
- From:Korean Journal of Pediatrics
2007;50(11):1116-1124
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Juvenile dermatomyositis (JDM) is the most common of the idiopathic inflammatory myopathies in children. The purpose of this study is to observe demographic, initial presentations, duration of time between disease onset and diagnosis, clinical manifestations and laboratory findings at diagnosis of patients with JDM. METHODS: Forty seven patients identified at Seoul National University Children's Hospital from January 1986 to May 2007. Medical records were reviewed retrospectively focusing on initial presentations, clinical manifestations and laboratory findings at the time of diagnosis of patients with JDM. RESULTS: Male and female patients were 25 and 22, respectively and sex ratio was 1.14:1. The average age at the time of diagnosis was 6.51 years. Skin rash (94%) was the most common symptom, followed by the proximal muscle weakness (89%). The disease activity score was 10.8. The duration between the onset of the skin rash and the muscle weakness and diagnosis was 7.18 and 4.70 months, respectively. The serum muscle enzymes, LDH, AST, CK and aldolase, were elevated in the patient with JDM. Autoimmune antibodies, antinuclear antibody, anti SSA antibody and anti SSB antibody, were negative findings. Electromyography findings were consistent with JDM in 88% of the patients, the muscle biopsy was in 91% and all MRI findings were compatible with those of patients with JDM. The most common symptom besides musculocutaneous lesions was the calcinosis (62.5%). The most common site of calcinosis was the pelvic area and buttocks. CONCLUSION: This study shows that the major symptoms are proximal muscle weakness and cutaneous lesion, and they are important to diagnose JDM.
